Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsored by: |
Pierre Fabre Medicament |
---|---|
Information provided by: | Pierre Fabre Medicament |
ClinicalTrials.gov Identifier: | NCT00757679 |
Evaluation of the antinociceptive effect of 7 weeks of treatment with milnacipran, compared to placebo, in fibromyalgia out-patients
Condition | Intervention | Phase |
---|---|---|
Fibromyalgia Syndrome |
Drug: Milnacipran |
Phase II |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Double-Blind, Placebo Control, Parallel Assignment, Safety/Efficacy Study |
Official Title: | Evaluation of the Antinociceptive and Analgesic Effects of Milnacipran. An Exploratory Placebo-Controlled Clinical Trial in Fibromyalgia Out-Patients |
Estimated Enrollment: | 80 |
Study Start Date: | September 2006 |
Estimated Study Completion Date: | October 2009 |
Ages Eligible for Study: | 18 Years to 70 Years |
Genders Eligible for Study: | Female |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contact: Yves MAINGUY, MD | +33 5 62 24 27 40 | yves.mainguy@pierre-fabre.com |
Switzerland | |
Clinical Pharmacology & Toxicology Multidisciplinary Pain Centre | Recruiting |
GENEVE, Switzerland | |
Contact: jules desmeules, MD 41 22 382 99 32 jules.desmeules@hcuge.ch | |
Principal Investigator: jules Desmeules, MD |
Principal Investigator: | Jules Desmeules, MD | Centre Hospitalier HUG Genève - SUISSE |
Study ID Numbers: | F02207 GE 205 |
Study First Received: | September 22, 2008 |
Last Updated: | September 22, 2008 |
ClinicalTrials.gov Identifier: | NCT00757679 History of Changes |
Health Authority: | Switzerland: Swissmedic |
Neurotransmitter Agents Adrenergic Agents Fibromyalgia Myofascial Pain Syndromes Psychotropic Drugs Pain Rheumatic Diseases Serotonin Uptake Inhibitors |
Serotonin Milnacipran Muscular Diseases Musculoskeletal Diseases Neuromuscular Diseases Analgesics Peripheral Nervous System Agents Antidepressive Agents |
Neurotransmitter Uptake Inhibitors Neurotransmitter Agents Molecular Mechanisms of Pharmacological Action Adrenergic Agents Adrenergic Uptake Inhibitors Physiological Effects of Drugs Psychotropic Drugs Pathologic Processes Neuromuscular Diseases Musculoskeletal Diseases Sensory System Agents Syndrome Therapeutic Uses Analgesics |
Antidepressive Agents Disease Myofascial Pain Syndromes Fibromyalgia Nervous System Diseases Rheumatic Diseases Serotonin Uptake Inhibitors Pharmacologic Actions Milnacipran Muscular Diseases Serotonin Agents Peripheral Nervous System Agents Central Nervous System Agents |